China Kangtai Cactus Biotech to Present at the Rodman & Renshaw Annual Global Investment Conference in New York on September 11, 2009

HARBIN, China, Sept. 9 /PRNewswire-Asia-FirstCall/ — China Kangtai Cactus
Biotech Inc. (OTC Bulletin Board: CKGT), a vertically integrated grower,
developer, manufacturer and marketer of a variety of cactus-based products in
China, will present at the Rodman and Renshaw Annual Global Investment
Conference to be held on September 9-11, 2009 in New York. China Kangtai
Cactus Biotech will present as part of the Asia Track program on September 11,
2009 at 1:10 p.m. ET in the Kennedy I Salon on the 4th floor of the New York
Palace Hotel.

A live webcast and slides of the presentation will be available at
http://www.wsw.com/webcast/rrshq15/ckgt.ob . The webcast will be available for
approximately three months. The PowerPoint presentation will be available at:
http://www.hawkassociates.com .

CEO Jinjiang Wang will be available to meet in scheduled sessions with
institutional investors at the conference on September 9-11 or in New York
from September 14-15 and in Southern California from September 17-18.
Institutional investors seeking to arrange a one on one meeting or
teleconference with management outside of the conference while management is
in the U.S. can contact Susan Zhou, 305-451-1888 or cactus@hawkassociates.com.

About China Kangtai Cactus Biotech, Inc.

China Kangtai Cactus Biotech, Inc. is a leading grower, developer,
producer, and marketer of cactus-derived products, including nutraceuticals,
nutritious food, health and energy drinks, beer, wine and liquor, extracts and
powders, and animal feed. China Kangtai controls over 387 acres of plants and
maintains an active R&D group that holds 18 product patents and is seeking
another 12. China Kangtai’s high-quality “green” products are sold throughout
China via a distribution network that covers 12 of China’s 23 provinces and
two of China’s four municipalities. More information may be found at
http://www.biocactus.com or via e-mail: chinakangtai@gmail.com.

An online investor relations kit and investment profile on China Kangtai
Cactus Biotech Inc. is available at
http://www.hawkassociates.com/profile/ckgt.cfm . To subscribe to future
releases via e-mail alert, visit http://www.hawkassociates.com/about/alert/ .

This news release contains forward-looking statements as defined by the
Private Securities Litigation Reform Act of 1995. Forward-looking statements
include statements concerning plans, objectives, goals, strategies, future
events or performance, and underlying assumptions and other statements that
are other than statements of historical facts. These statements are subject to
uncertainties and risks including, but not limited to, product and service
demand and acceptance, changes in technology, economic conditions, the impact
of competition and pricing, government regulation, and other risks contained
in reports filed by the company with the Securities and Exchange Commission.
All such forward-looking statements, whether written or oral, and whether made
by or on behalf of the company, are expressly qualified by the cautionary
statements and any other cautionary statements which may accompany the
forward-looking statements.

    For more information, please contact:

    Investor Contact:
     Hawk Associates
     Susan Zhou
     Tel:   +1-305-451-1888
     Email: cactus@hawkassociates.com

SOURCE China Kangtai Cactus Biotech Inc.